Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs
Patent includes broad claims for "Gut Microbiota Bioactivated PDE4 Inhibitor Precursors" with similar structure to PALI-2108 and PALI-1908
This patent family provides Composition of Matter coverage beyond 2042
PALI-2108 is in development to treat patients with active moderate-to-severely active Ulcerative Colitis (UC)
PALI-1908 is in development to treat patients with active fibro stenotic Crohn's Disease (CD)
Posted In: PALI